Date Time
Path of least resistance: a novel tuberculosis regimen shortens treatment course for patients
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A multi-institutional research team led by MUSC investigator Susan Dorman, M.D., reports in the May 6 issue of the New England Journal of Medicine that a four-month treatment regimen using rifapentine is effective for treating TB. Shortening the treatment duration is an important step toward increased patient adherence. Dorman is a professor in the College of Medicine at MUSC.
A phase III clinical trial led by an investigator at the Medical University of South Carolina found that a novel four-month regimen was just as effective at treating tuberculosis as the standard six-month regimen. The findings are reported in the May 6, 2021 New England Journal of Medicine.
OFF RADAR: ‘Wildflowers of Maine Islands’ and ‘Maine in Winter’
A great new field guide and a collection of stories from the Maine Metaphor series
By Dana Wilde
“Wildflowers of Maine Islands: The Downeast and Acadia Coasts,” by Glen H. Mittelhauser; University of Maine Press, Orono, Maine, 2021; 392 pages, softcover, $28.
One of the best field guides to wildflowers I’ve used every summer for years is University of Maine Press’s “The Plants of Acadia National Park,” partly because its photos so clearly depict each plant and flower, and partly because its key system is so easy to use. Now UMaine Press has released another guide by one of that book’s authors, Glen Mittelhauser.
MUSC physician wins $9.9 million contract to run trials for the Tuberculosis Trials Consortium
Susan Dorman, M.D., an infectious disease physician at the Medical University of South Carolina (MUSC), was recently awarded a 10-year, $9.9 million contract by the Centers for Disease Control and Prevention to run trials for the Tuberculosis Trials Consortium (TBTC).
The TBTC is a collaboration of researchers whose goal is to improve the diagnosis, management and prevention of tuberculosis (TB) around the world. Dorman, who has dedicated her career to studying the disease, serves as a TB medical consultant for the South Carolina Department of Health and Environmental Control and leads research efforts to improve TB treatment and prevention.
Researcher awarded $9 9M for tuberculosis treatment and prevention miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.